Is Pharmaron Beijing Co., stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Pharmaron Beijing Co., pays dividends. Last time was Friday 26th of July 2024 where the investors holding the stock on Thursday 27th of June 2024 were paid HKD0.23614 per share. Over the last 5 times between 2020 and 2024, Pharmaron Beijing Co., has paid HKD2.22588 with an average of HKD0.45 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Pharmaron Beijing Co., 10 years ago, but if you had invested on Thursday 28th of November 2019 when the price was HKD18.78, you would have made a loss of HKD-9.90 per share or -52.72%
Yes, the average daily trading liquidity for Pharmaron Beijing Co., is HKD3.59 million. You should therefore be able to get in and out of your positions relatively fast.
Pharmaron Beijing Co., has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.36, the company's ability to pay off the debt is normal. Pharmaron Beijing Co., has a good net profit margin of 12.92% and should have high tolerances against inflation.
We have calculated the inflation risk for Pharmaron Beijing Co., to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.